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Objective: To investigate hypocholesterolemic and hypoglycemic potential of citrus peel
extract and powder using rodent experimental modeling.
Methods: Considering the fact, rat feeding trial was carried out for a period of 56 d
to access the prophylaxis of citrus peel ﬂavonoids by employing normal (study I),
hyperglycemic (study II) and hypercholesterolemic (study III) rats. Each study was
further divided into three groups to ensure the provision of selected diets, i.e.,
control, functional and nutraceutical diets. Each study was further divided into three
groups to ensure the provision of selected diets, i.e., control, functional and nutra-
ceutical diets.
Results: Declining trend for total cholesterol was observed in all studies with maximum
reduction (8.55%) in rat group fed on nutraceutical diet in study III. Likewise, levels of
low density lipoproteins and triglycerides reduced 11.39% and 7.89% respectively in
hypercholesterolemic rats. Moreover, nutraceutical diet alleviated the sera glucose level
by 8.96% in study II.
Conclusions: Conclusively, inclusion of citrus peel bioﬂavonoids in dietary therapies is
a promising strategy to modulate lipidemic and glycemic attributes without imparting any
deleterious effect on hematological parameters.1. Introduction
Globally, emerging trends are shifting consumer's cognizance
towards the peculiar role of food in diseases management such as
cardiovascular complications, cancer, arthritis and diabetes. This
veracity has made gap between food and drugs very narrow in
curtailing the life associated ailments [1]. In this reverence, dietary
tools place emphasis on the dynamic facets of phytonutrients as
they put beneﬁcial effects on human health [2]. Taking in
account the current scenario, novel health strategies assentingto the supplementation of phytochemicals to curb the onset of
chronic disorders are dominating. Epidemiological studies have
proved a healthy connection between functional ingredients of
food and well-being of vulnerable group of the people [3]. This
has drawn the concept of functional and nutraceuticals
components in food, which wield beneﬁcial effects beyond
basic nutrition [4]. Amongst these ingredients of food, plant
based functional components are extensively being employed
for ameliorating non-communicable diseases owing to their
ease to access, safety, acceptability and low cost [5,6].
Citrus peel, a byproduct of food processing industry, has a
wide array of nutraceutical moieties that play signiﬁcant roles
against various physiological threats. It was noticed that citrus
peel (orange) is a rich source of phenolic compounds that
include phenolic acids and ﬂavonoids constituting 147.6 mg/g of
dry orange peel [7]. There are more than 4 000 structural variants
of ﬂavonoids that have been identiﬁed and characterized for their
prophylactic potential. Among them, citrus peel derivedarticle under the CC BY-NC-ND license (http://
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providing therapeutic effects against various health related
disorders [8]. There are two important glycosylated ﬂavanones
in citrus peel, namely, narirutin and hesperidin. However,
hesperidin is more imperative for its therapeutic effects [9].
Considering numerous varieties of citrus family, Citrus
sinensis is the major source of hesperidin ranging from 6.98 to
10.80 mg/g dried matter [10]. Studies have revealed its
pharmacological and biological viewpoints such as
hypolipidemic, hypoglycemic and anti-inﬂammatory perspec-
tives. Due to its ease in accessibility of fruits by-products, citrus
peel is one of the cheap sources of polyphenols for value added
and designer food products [11].
In developing countries, hyperlipidemia resulting from ﬂuctu-
ations in lipid homeostasis, is the leading cause of cardiovascular
diseases or atherosclerosis. Many factors are involved in the
maintenance of blood cholesterol level that effect both intracellular
and extracellular cholesterol metabolism [12]. Two important
enzymes, 3-hydroxy-3-methyl-glutaryl-CoA 3 reductase as well
as acyl CoA: cholesterolO-acyltransferase, present in the body that
regulate cholesterol synthesis and modulate triglyceride level [13].
In this context, citrus peel ﬂavonoids have ability to inﬂuence
vascular endothelial cells in experimental models of
hypercholesterolemia. In most animal species including human,
inhibitors of 3-hydroxy-3-methyl-glutaryl-CoA reductase are
effective in lowering plasma cholesterol level thus normalize both
intracellular and extracellular cholesterol metabolism.
Furthermore, acyl CoA: cholesterol O-acyltransferase is involved
in catalysis of cholesterol esteriﬁcation, hepatic secretion of very
low-density lipoproteins, cholesterol absorption and its accumula-
tion in vascular wall. Similarly, acyl CoA: cholesterol O-acyl-
transferase inhibitors are being used in cholesterol lowering drugs
due to its hypocholesterolemic potential [14]. It is revealed from the
previous data that hesperidin (0.08%) reducesweight of fatty tissues
& liver, hepatic steatosis, retinol binding protein (involved in lipid
metabolism) and total plasma cholesterol [15]. Among
polymethoxylated ﬂavones, nobiletin (0.1%) restored plasma and
hepatic high density lipoproteins (HDL) cholesterol level with
simultaneous decrement in hepatic triglycerides in diet induced
hypercholesterolemic rats [16].
Diabetes is the most common metabolic syndrome related
with expansion of coronary diseases. It is a multifunctional
disorder that is characterized by hyperglycemia, abnormality in
lipoproteins and increased oxidative stress due to which insulin
secreting pancreatic beta cells become damaged [17]. Research
has conﬁrmed that polyphenolic and ﬂavonoids rich diet has a
potential to alleviate blood glucose level [18]. Substantial facts
have divulged the role of citrus peel as an anti-diabetic agent
by the reason of its strong antioxidant potential. The citrus peel
allied bioﬂavonoids: hesperidin and nobiletin, attenuate hyper-
glycemic state by alleviating activities of phosphoenol pyruvate,
glucose-6-phosphatase and a amylase whilst ameliorating
glucokinase action and insulin secretion in blood [19].
Interestingly, citrus peels are considered as agro-waste material
and are thought to impart negative impact by aggravating the
legal boundaries and hygienic status of metropolitans. None-
theless, their exploitation in dietary regimen will not only offer
as source of cost effective and innovative generation therapeu-
tics but also enhance nutritional value of conventional
edibles [20].2. Material and methods
2.1. Procurement of raw material and powder
preparation
The research project was conducted in Functional and Nu-
traceutical Food Research Section, National Institute of Food
Science and Technology, University of Agriculture, Faisalabad
(UAF), Pakistan. Citrus (Orange) was procured from local
market, Faisalabad, considering the quality attributes like uni-
formity in color, size, shape and abrasion free trailed by
washing. For the efﬁcacy study, diagnostic kits were purchased
from Sigma–Aldrich, Bioassay (Bioassays Chemical Co. Ger-
many) and Cayman Chemicals (Cayman Europe, Estonia).
Citrus peels were separated from fruits and sun dried fol-
lowed by grinding to a ﬁne powder using grinder. Resultant peel
powder was stored for the extraction of biomolecules and bio-
evaluation trial.
2.2. Preparation of citrus peel extract
Citrus peel extract was prepared using water and methanol
(50% v/v) for time interval of 45 min at 50 C using the
guidelines of Sultan et al. [21], with some modiﬁcations trailed
by ﬁltration and rotatory evaporation.
2.3. Efﬁcacy study
A rodent trial was conducted to explore the therapeutic po-
tential of the representative citrus peel based functional and
nutraceutical diets against lifestyle related metabolic syndrome
i.e. hypercholesterolemia and hyperglycemia. For the intent, 60
male Sprague Dawley rats were acquired from National Institute
of Health, Islamabad, Pakistan and adjusted in the Animal Room
of National Institute of Food Science and Technology, UAF.
The animals were adapted by feeding the control diet for course
of 7 d and by maintaining temperature (23 ± 2) C and relative
humidity 55% ± 5% throughout the trial. At the beginning, some
of them were slaughtered to obtain baseline values. In rat
modeling, three independent studies were executed separately;
study I, study II and study III. Rats were fed with control diet,
diet containing citrus peel powder and diet containing citrus peel
extracts in control, functional diet and nutraceutical diet groups
respectively in all three studies. Study I was consisted of rats fed
on normal diet, whereas in study II & III, high glucose &
cholesterol rich diets were employed, respectively. In each
study, three groups of rats were formed depending on variations
in their diets; control, functional and nutraceutical diets were
used to assess its effect on different biological attributes like
total cholesterol, HDL, low density lipoproteins (LDL), tri-
glycerides, glucose and insulin level.
2.3.1. Ethical approval
Ethics approval was given by the head of the National
Institute of Food Science and Technology, UAF, Pakistan, by
reviewing the suggestions of Animal Experimentation Ethics
Committee, UAF. Animal experiments were conducted in
accordance with the instructions for the care and use provided by
the committee and instructed by the university.
Figure 1. Feed intake in different studies (g/rat/day). (a) Study I: Normal
rats; (b) Study II: Hyperglycemic rats; and (c) Study III: Hypercholester-
olemic rats.
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The net feed and water intakes were estimated on daily basis
by following the protocol of Wolf and Weidbrode [22].
2.3.3. Body weight gain
The change in body weight was monitored weekly to assess the
inﬂuence of functional and nutraceutical diets on experimental rats.
2.3.4. Serum lipid proﬁle
Serum lipid proﬁles including cholesterol method of Kim
et al. [23], high density lipoproteins (HDL cholesterol
precipitant) procedure of Alshatwi et al. [24], low density
lipoproteins method of Alshatwi et al. [24] and triglycerides
(GPO–PAP) guidelines of Demonty et al. [25] were measured
with their respective protocols.
2.3.5. Serum glucose and insulin levels
The collected serum of rats was assessed according to
glucose (GOD-PAP) method of Kim et al. [23] and insulin
measuring procedure of Ahn et al. [26].
2.3.6. Hematological analysis
Red blood cells as well as white blood cell indices were
estimated by following the protocol of Al Haj et al. [27] whilst
platelets count was calculated according to the method of
Kamatani et al. [28].
2.4. Statistical analysis
Data obtained was interpreted by statistical analysis to
evaluate the level of signiﬁcance and comparison of means as
described by Steel et al. [29].
3. Results
3.1. Feed and drink intakes
Efﬁcacy trial was conducted to explore health promoting
aspects of citrus peel powder and its extract on following pa-
rameters. Mean squares regarding the feed intake elucidated
signiﬁcant differences as function of treatment as well as study
weeks. Means relating to feed intake (Figure 1) in study I
(normal diet) have revealed maximum feed intake in rat groups
fed on functional and nutraceutical diets with (16.76 ± 0.45) and
(16.55 ± 0.34) g/rat/day respectively, as compared to control
group (15.22 ± 0.38) g/rat/day. Feed intake increased momen-
tously in the course of time from (13.69 ± 0.25) to
(19.38 ± 0.92) g/rat/day during the whole study. However, in
study II (high sucrose diet), overall means indicated that rat
group fed on control diet has more (17.04 ± 0.67) g/rat/day feed
consumption followed by functional (16.90 ± 0.41) g/rat/day
and nutraceutical diets (16.74 ± 0.87) g/rat/day. Elevation in
time intervals has favored feed consumption from (14.12 ± 0.16)
g/rat/day at 1st week to (21.03 ± 0.73) g/rat/day at the end of
study. Likewise, in study III (high cholesterol diet), control
group indicated feed intake of (18.23 ± 0.87) g/rat/day higher in
contrast to functional [(17.53 ± 0.74) g/rat/day] and nutraceutical
group [(16.71 ± 0.48) g/rat/day]. Moreover, time duration also
has a crucial role in enhancing feed intake, as at the beginning it
was (15.46 ± 0.73) g/rat/day that mounted to (20.74 ± 1.16) g/
rat/day at ﬁnal week.Mean squares for drink intake were affected signiﬁcantly due
to study intervals along with a non-signiﬁcant behavior for
treatments. Means relating to drink intake of rats (Figure 2) in
study I, showed maximum intake in functional and nutraceutical
diets based groups (23.02 ± 0.54) and (23.10 ± 0.48) mL/rat/day,
correspondingly that was at par to control group (22.23 ± 0.39)
mL/rat/day, nevertheless, increased from (19.43 ± 0.23) to
(25.92 ± 1.02) mL/rat/day during 56 d trial. On the contrary, in
study II, values observed for this trait were (23.73 ± 1.04),
(23.47 ± 0.48) and (23.39 ± 0.38) mL/rat/day for control, func-
tional and nutraceutical rat groups, respectively. Rats provided
with high cholesterol diet (study III), revealed drink consumption
for control, functional and nutraceutical groups as (24.33 ± 0.74),
(24.23 ± 0.65) and (24.18 ± 0.43) mL/rat/day, correspondingly
that enhanced from baseline value of (21.23 ± 0.86) to
(27.78 ± 1.14) mL/rat/day at the end of trial (Figure 2).
Figure 2. Drink intake in different studies (mL/rat/day). (a) Study I:
Normal rats; (b) Study II: Hyperglycemic rats; and (c) Study III: Hyper-
cholesterolemic rats.
Figure 3. Body weight in different studies (g/rat). (a) Study I: Normal rats;
(b) Study II: Hyperglycemic rats; and (c) Study III: Hypercholesterolemic
rats.
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Mean squares for body weights of rats in different studies
have illuminated signiﬁcant effect of treatments and study
weeks. It is evident from Figure 3 (study I) that body weight was
signiﬁcantly higher in functional and nutraceutical groups
(165.95 ± 4.98) and (167.59 ± 5.11) g/rat, respectively in
contrast to control group (159.47 ± 3.65) g/rat. Body weight in
control group increased with passage of time ranging from
(130.57 ± 4.76) to (225.35 ± 7.54) g/rat but in functional and
nutraceutical groups increasing rate in body weight did not
coincide to that of control group. In contrary to study I, the body
weights of rats fed on high sucrose diet (study II) increased
signiﬁcantly and effect was more prominent in control group
[(175.89 ± 6.32) g/rat] than in functional [(173.18 ± 7.78) g/rat]
and nutraceutical [(168.60 ± 6.12) g/rat] groups. Same trend wasobserved in study III; rats fed on normal diet gained more body
weight [(188.45 ± 7.53) g/rat] as compared to functional and
nutraceutical groups [(180.40 ± 6.74) and (176.06 ± 6.24) g/rat],
correspondingly. However, as function of time, increasing trend
in body weight of rats fed on nutraceutical diet was lower as
compared to functional and control groups from 0 to 56 d
(Figure 3).
3.3. Hypercholesterolemic perspectives
3.3.1. Cholesterol
Mean squares corresponding to total cholesterol showed
signiﬁcant effect of diet in study II and III with non-signiﬁcant
impact of time intervals in all studies. While, their interaction
exerted momentous effect on cholesterol level of rats in study
III. In study I, maximum cholesterol was recorded in control
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[(79.29 ± 2.53) mg/dL] and nutraceutical [(79.19 ± 2.68) mg/dL]
groups (Table 1). During the eight-week trial, cholesterol in
control group increased from (80.45 ± 3.21) to (82.68 ± 3.35)
mg/dL while decreasing trend was observed for functional from
(79.45 ± 2.65) to (78.48 ± 2.29) mg/dL and nutraceutical from
(80.08 ± 2.98) to (78.40 ± 3.87) mg/dL groups. Overall diets
containing citrus peel powder and extract delineated percent
reduction in cholesterol level by 1.15% and 2.05%, respectively.
Means for cholesterol in study II (high sucrose diet) depicted the
highest value for control group [(115.20 ± 4.60) mg/dL] that
signiﬁcantly reduced to (107.08 ± 4.28) mg/dL in functional and
(106.24 ± 3.18) mg/dL in nutraceutical treated groups. Likewise,
in control group cholesterol increased as function of study in-
tervals from (108.90 ± 5.44) to (120.23 ± 6.01) mg/dL but
decreased in functional and nutraceutical groups. It was calcu-
lated that cholesterol level reduced by 3.83% and 5.57% in
functional and nutraceutical groups, correspondingly. Maximum
reduction was found in nutraceutical group from
(109.90 ± 5.49) at 0 d to (103.77 ± 3.11) mg/dL at the end of
study.
However, in study III (rats fed on high cholesterol diet)
showed maximum cholesterol [(138.37 ± 5.53) mg/dL] in con-
trol group but the value for this trait was reduced in functional
[(124.47 ± 4.97) mg/dL] and nutraceutical groups
[(122.11 ± 3.66) mg/dL]. Furthermore, rat group fed on control
diet showed increment in cholesterol from (127.78 ± 3.83) to
(147.65 ± 5.90) mg/dL during whole study, whilst diets con-
taining citrus peel powder and extract decreased cholesterol
level signiﬁcantly from (129.18 ± 3.87) to (121.68 ± 4.86) mg/
dL and (128.45 ± 5.13) to (117.46 ± 3.52) mg/dL, corre-
spondingly. It was observed that nutraceutical diet elicited more
percent decrement in cholesterol level (8.55%) in contrast to
functional diet (5.80%).
3.3.2. HDL
It is obvious from mean squares that study intervals as well as
interaction exhibited non-signiﬁcant differences on HDL level in
different studies. Mean values (Table 2) for this trait in study I
(normal diet) showed that neither functional nor nutraceutical
based diet altered HDL momentously and values for control,
functional and nutraceutical groups were (33.23 ± 1.23),
(33.86 ± 1.85) and (34.40 ± 1.61) mg/dL, respectively. How-
ever, HDL level has increased from (33.21 ± 1.32) toTable 1
Means for cholesterol (mg/dL) of rats in different studies.
Studies Diet groups Stu
0
Study I Control 80.45 ± 3.21
Functional 79.45 ± 3.97
Nutraceutical 80.08 ± 2.98
Means 79.99 ± 2.79
Study II Control 108.90 ± 5.44
Functional 109.58 ± 4.38
Nutraceutical 109.90 ± 5.49
Means 109.46 ± 4.37
Study III Control 127.78 ± 3.83
Functional 129.18 ± 3.87
Nutraceutical 128.45 ± 5.13
Means 128.47 ± 3.85
Study I: Normal rats; Study II: Hyperglycemic rats; Study III: Hypercholes(33.25 ± 1.53) mg/dL, (33.78 ± 1.15) to (33.92 ± 1.49) mg/dL
and (34.23 ± 1.02) to (34.55 ± 1.55) mg/dL in control, functional
and nutraceutical groups, correspondingly from 0 to 56 d.
Conclusively, it revealed that citrus peel extract has more ten-
dencies to enhance HDL level by 0.95% as compared to peel
powder (0.43%).
In study II (high sucrose diet), HDL values for control,
functional and nutraceutical groups were (39.50 ± 1.39),
(40.45 ± 2.51) and (39.25 ± 1.35) mg/dL, respectively. There
was non-momentous increase in HDL level of all rat groups that
was highest in nutraceutical group from (38.97 ± 1.55) at 0 d to
(39.48 ± 1.44) mg/dL at termination of study. However, HDL
level raised by 0.87% and 1.33% in rat groups fed on citrus peel
functional and nutraceutical supplemented diets, respectively. In
study III, means for control, functional as well as nutraceutical
groups were (45.53 ± 1.52), (47.40 ± 2.29) and (46.86 ± 2.45)
mg/dL, correspondingly. For 56 d, progressive decrease in HDL
level from (45.57 ± 1.82) to (45.49 ± 1.33) mg/dL was recorded
in control group, while this trait was increased from
(46.34 ± 2.34) to (46.85 ± 2.54) mg/dL and (47.12 ± 2.31) to
(47.98 ± 2.54) mg/dL in functional and nutraceutical groups,
respectively. There was 1.11% and 1.83% rise in HDL level of
hypercholesterolemic rats provided with functional and nutra-
ceutical diets.
3.3.3. LDL
It is evident from mean squares that diet has signiﬁcantly
affected LDL in all studies except in normal rat group (study I).
Nevertheless, LDL has changed signiﬁcantly in study I and III as
a function of interaction for diet and study intervals but with
passage of time non-momentous trend was observed in all
studies. Means for study I (Table 3) indicated LDL level as
(31.83 ± 1.34) mg/dL in control group that decreased to
(31.63 ± 1.63) and (31.61 ± 1.95) mg/dL in functional and
nutraceutical groups, correspondingly. However, with passage
of time LDL varied non-signiﬁcantly from (30.31 ± 0.90) to
(31.65 ± 1.58) mg/dL in control group while in functional and
nutraceutical groups reduction was from (31.96 ± 1.65) to
(31.29 ± 1.21) mg/dL and (32.27 ± 1.29) to (31.25 ± 1.54) mg/
dL, respectively. It was concluded that LDL value decreased by
2.07% and 3.13% in rats fed on functional and nutraceutical
groups, correspondingly.
LDL value for control group (study II) was (58.29 ± 1.74)
mg/dL that momentously decreased in functional anddy intervals (days) Means
28 56
81.05 ± 2.83 82.68 ± 3.35 81.39 ± 2.85
79.95 ± 2.36 78.48 ± 2.29 79.29 ± 2.53
79.25 ± 2.84 78.40 ± 3.87 79.19 ± 2.68
80.08 ± 3.20 79.85 ± 2.56 –
116.47 ± 3.49 120.23 ± 6.01 115.20 ± 4.60
106.30 ± 4.25 105.38 ± 3.16 107.08 ± 4.28
105.04 ± 4.20 103.77 ± 3.11 106.24 ± 3.18
109.27 ± 4.37 109.79 ± 4.31 –
139.69 ± 6.98 147.65 ± 5.90 138.37 ± 5.53
122.56 ± 3.67 121.68 ± 4.86 124.47 ± 4.97
120.43 ± 6.01 117.46 ± 3.52 122.11 ± 3.66
127.56 ± 5.10 128.93 ± 5.15 –
terolemic rats.
Table 2
Means for HDL (mg/dL) of rats in different studies.
Studies Diet groups Study intervals (days) Means
0 28 56
Study I Control 33.21 ± 1.32 33.23 ± 1.41 33.25 ± 1.53 33.23 ± 1.23
Functional 33.78 ± 1.15 33.89 ± 1.42 33.92 ± 1.49 33.86 ± 1.85
Nutraceutical 34.23 ± 1.02 34.44 ± 1.34 34.55 ± 1.55 34.40 ± 1.61
Means 33.74 ± 1.34 33.85 ± 1.32 33.91 ± 1.29 –
Study II Control 39.57 ± 1.58 38.82 ± 1.43 38.52 ± 1.51 38.98 ± 1.39
Functional 38.97 ± 2.01 39.18 ± 2.34 39.30 ± 2.39 39.15 ± 2.51
Nutraceutical 39.97 ± 1.55 40.22 ± 1.32 40.50 ± 1.44 40.23 ± 1.35
Means 39.50 ± 1.38 39.40 ± 1.54 39.45 ± 1.65 –
Study III Control 45.57 ± 1.82 45.55 ± 1.65 45.49 ± 1.33 45.53 ± 1.52
Functional 46.34 ± 2.34 46.72 ± 2.35 46.85 ± 2.54 46.63 ± 2.29
Nutraceutical 47.12 ± 2.31 47.66 ± 2.61 47.98 ± 2.54 47.58 ± 2.45
Means 46.34 ± 2.54 46.64 ± 2.55 46.77 ± 2.41 –
Study I: Normal rats; Study II: Hyperglycemic rats; Study III: Hypercholesterolemic rats.
Table 3
Means for LDL (mg/dL) of rats in different studies.
Studies Diet groups Study intervals (days) Means
0 28 56
Study I Control 30.31 ± 0.90 30.98 ± 0.89 31.65 ± 1.58 31.83 ± 1.34
Functional 31.96 ± 1.65 31.64 ± 1.7 31.29 ± 1.21 31.63 ± 1.63
Nutraceutical 32.27 ± 1.29 31.32 ± 0.17 31.25 ± 1.54 31.61 ± 1.95
Means 31.48 ± 1.34 31.31 ± 1.98 32.25 ± 1.20 –
Study II Control 55.78 ± 1.67 57.88 ± 2.31 61.23 ± 1.83 58.29 ± 1.74
Functional 57.63 ± 2.39 55.33 ± 1.54 54.67 ± 2.18 55.88 ± 1.32
Nutraceutical 56.73 ± 2.26 52.63 ± 2.10 51.93 ± 2.07 53.76 ± 2.15
Means 56.71 ± 2.45 55.28 ± 1.65 55.94 ± 1.87 –
Study III Control 63.25 ± 1.89 68.85 ± 3.44 71.84 ± 3.59 67.98 ± 2.71
Functional 64.86 ± 2.59 60.64 ± 2.42 59.16 ± 1.77 61.55 ± 3.07
Nutraceutical 62.99 ± 3.14 56.94 ± 1.70 55.97 ± 2.23 58.63 ± 2.34
Means 63.70 ± 2.54 62.14 ± 3.29 62.32 ± 3.34 –
Study I: Normal rats; Study II: Hyperglycemic rats; Study III: Hypercholesterolemic rats.
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respectively. It was interpreted that reduction in LDL was
maximum in rats fed on peel extract supplemented diet (nutra-
ceutical group) from (56.73 ± 2.26) to (51.93 ± 2.07) mg/dL.
However, both functional and nutraceutical diets has signiﬁ-
cantly reduced LDL value by 5.12% and 8.45%, correspond-
ingly. Substantial differences in LDL (study III) were measured
in nutraceutical [(58.63 ± 2.34) mg/dL] and functional
[(61.55 ± 3.07) mg/dL] groups as compared to control
[(67.98 ± 2.71) mg/dL]. It was observed that during 56 day
efﬁcacy study, LDL increased in control from (63.25 ± 1.89) to
(71.84 ± 3.59) mg/dL, nevertheless, decreasing trend was found
in functional and nutraceutical groups from (64.86 ± 2.59) to
(59.16 ± 1.77) mg/dL and (62.99 ± 3.14) to (55.97 ± 2.23) mg/
dL, correspondingly. There was 8.78% and 11.39% reduction in
LDL level of rats fed on functional and nutraceutical diets,
correspondingly.
3.3.4. Triglyceride
Mean squares for the effect of diet has signiﬁcantly changed
triglycerides in study II and III while interaction varied this trait
momentously only in study III. Mean values for triglycerides
(Table 4) in study I in control, functional and nutraceutical
groups were (72.11 ± 2.32), (71.73 ± 2.65) and (69.79 ± 3.65)
mg/dL, correspondingly. It was observed that triglycerides incontrol group increased from (71.24 ± 2.10) to (72.98 ± 2.85)
mg/dL but decreased in functional and nutraceutical groups from
(72.67 ± 2.90) to (71.13 ± 2.34) mg/dL and (71.34 ± 2.45) to
(68.82 ± 3.44) mg/dL, respectively. Overall, serum triglycerides
decreased by 2.11% and 3.52% for functional and nutraceutical
groups. Similarly, in study II, mean values for control, func-
tional and nutraceutical groups differed substantially, i.e.,
(79.80 ± 3.99), (74.06 ± 2.96) and (73.47 ± 2.78) mg/dL,
correspondingly. Maximum reduction for triglycerides was
noted in nutraceutical group from (76.12 ± 3.08) to
(71.68 ± 2.23) mg/dL. Conclusively, it was inferred that diet
containing citrus peel powder and extract has signiﬁcantly
reduced triglycerides by 4.16% and 5.83%, correspondingly.
However, for study III triglycerides level increased to
(98.36 ± 3.93) mg/dL in control group but diet containing 10%
citrus peel powder (functional) and 5% peel extract (nutraceuti-
cal) suppressed the values for this trait to (91.82 ± 3.67) and
(89.37 ± 3.57) mg/dL, respectively. During course of eight-week
study, nutraceutical group exhibited pronounced alleviation in
triglycerides from (93.78 ± 4.68) to (86.38 ± 4.31) mg/dL.
Similarly, in functional group, triglyceride decreased from
(94.87 ± 2.84) to (89.71 ± 3.58) mg/dL whereas control group
showed signiﬁcant increase in triglyceride from baseline value to
the end of study (92.14 ± 2.76) to (103.21 ± 5.16) mg/dL.
However, effect of nutraceutical diet was more dominant in
Table 4
Means for triglycerides (mg/dL) of rats in different studies.
Studies Diet Study intervals (days) Means
0 28 56
Study I Control 71.24 ± 2.10 72.13 ± 2.43 72.98 ± 2.85 72.11 ± 2.32
Functional 72.67 ± 2.90 71.39 ± 2.65 71.13 ± 2.34 71.73 ± 2.65
Nutraceutical 71.34 ± 2.45 69.21 ± 3.46 68.82 ± 3.44 69.79 ± 3.65
Means 71.75 ± 2.43 70.91 ± 2.54 70.97 ± 2.32 –
Study II Control 76.38 ± 3.05 80.27 ± 3.21 82.75 ± 3.31 79.80 ± 3.99
Functional 75.87 ± 3.79 73.60 ± 2.94 72.71 ± 2.18 74.06 ± 2.96
Nutraceutical 76.12 ± 3.08 72.63 ± 2.34 71.68 ± 2.23 73.47 ± 2.78
Means 76.12 ± 3.17 75.50 ± 3.87 75.71 ± 3.54 –
Study 111 Control 92.14 ± 2.76 99.73 ± 3.98 103.21 ± 5.16 98.36 ± 3.93
Functional 94.87 ± 2.84 90.88 ± 3.63 89.71 ± 3.58 91.82 ± 3.67
Nutraceutical 93.78 ± 4.68 87.95 ± 3.51 86.38 ± 4.31 89.37 ± 3.57
Means 93.59 ± 3.74 92.85 ± 2.98 93.10 ± 3.81 –
Study I: Normal rats; Study II: Hyperglycemic rats; Study III: Hypercholesterolemic rats.
Humaira Ashraf et al./Asian Pac J Trop Biomed 2017; 7(10): 870–880876reducing serum triglyceride level (7.89%) in contrast to functional
diet (5.43%).
3.4. Hyperglycemic perspectives
3.4.1. Glucose
Statistical analysis regarding glucose delineated that diet
exhibited signiﬁcant differences on glucose in study II and III
whereas interaction of diet and study intervals exerted momentous
impact only in study II. Mean values for glucose (Table 5) in
control, functional and nutraceutical groups varied as
(92.45 ± 3.32), (89.92 ± 2.64) and (89.35 ± 2.76) mg/dL,
respectively in study I. In control group, glucose increased from
(91.87 ± 3.67) to (92.74 ± 3.98) mg/dL while in functional and
nutraceutical groups decreased from (90.56 ± 3.62) to
(89.22 ± 2.56) mg/dL and (91.08 ± 3.65) to (88.44 ± 2.78) mg/dL,
respectively. Maximum reduction (1.69%) was observed in
nutraceutical group as compared to functional group (0.98%).
In study II, maximum glucose concentration was noticed in
control group [(128.44 ± 3.85) mg/dL], followed by functional
[(115.08 ± 4.60) mg/dL] and nutraceutical group
[(113.73 ± 5.68) mg/dL]. It was expounded that diets containing
citrus peel powder and extract decreased glucose from
(119.56 ± 3.58) to (111.03 ± 3.33) mg/dL and (120.12 ± 5.22) to
(109.35 ± 3.28) mg/dL, correspondingly whereas increased from
(118.98 ± 4.75) to (135.84 ± 5.43) mg/dL in control group. BothTable 5
Means for glucose level (mg/dL) of rats in different studies.
Studies Diet Stu
0
Study I Control 91.87 ± 3.67
Functional 90.56 ± 3.62
Nutraceutical 91.08 ± 3.65
Means 91.67 ± 3.52
Study II Control 118.98 ± 4.75
Functional 119.56 ± 3.58
Nutraceutical 120.12 ± 5.22
Means 119.55 ± 3.61
Study III Control 96.81 ± 2.90
Functional 98.25 ± 3.93
Nutraceutical 97.67 ± 3.90
Means 97.57 ± 3.87
Study I: Normal rats; Study II: Hyperglycemic rats; Study III: Hypercholesfunctional and nutraceutical diets has signiﬁcantly decreased
plasma glucose level by 7.13% and 8.96%, respectively.
Maximum glucose value (101.78 ± 3.05) mg/dL was observed
for control group in study III (high cholesterol diet) that reduced
to (96.60 ± 2.98) mg/dL in functional and (94.98 ± 3.56) mg/dL
in nutraceutical groups. Similarly, maximum reduction in serum
glucose level was measured for nutraceutical group that changed
signiﬁcantly from (97.67 ± 3.90) to (93.06 ± 3.72) mg/dL as a
function of study intervals. However, both functional and nu-
traceutical groups have percent reduction of about 2.87% and
4.71%, correspondingly.
3.4.2. Insulin
Mean squares relevant to insulin depicted signiﬁcant impact
of diet only in study II while this trait was no signiﬁcant as
function of intervals and interaction in all studies. In study I,
mean values for insulin (Table 6) were (9.07 ± 0.76) (control
group), (9.16 ± 0.78) (functional group) and (9.42 ± 0.47) mU/
mL (nutraceutical group), respectively. Insulin level increased in
functional and nutraceutical groups from (9.07 ± 0.47) to
(9.25 ± 0.67) mU/mL and from (9.26 ± 0.31) to (9.55 ± 0.78)
mU/mL, respectively. Both citrus peel powder and extract
enhanced insulin secretion by 0.98% and 1.69% respectively as
compared to control group. Likewise, in study II, means for
insulin in control group was (10.20 ± 0.87) mU/mL, followed by
functional and nutraceutical groups with (10.70 ± 0.65) anddy intervals (days) Means
28 56
92.75 ± 3.71 92.74 ± 3.98 92.45 ± 3.32
89.99 ± 2.69 89.22 ± 2.56 89.92 ± 2.64
88.54 ± 2.65 88.44 ± 2.78 89.35 ± 2.76
90.43 ± 3.76 90.13 ± 3.98 –
130.52 ± 6.52 135.84 ± 5.43 128.44 ± 3.85
114.65 ± 4.58 111.03 ± 3.33 115.08 ± 4.60
111.73 ± 3.61 109.35 ± 3.28 113.73 ± 5.68
118.98 ± 4.89 118.74 ± 4.76 –
102.68 ± 3.08 105.85 ± 3.17 101.78 ± 3.05
96.13 ± 2.78 95.43 ± 2.86 96.60 ± 2.98
94.24 ± 3.76 93.06 ± 3.72 94.98 ± 3.56
97.68 ± 3.67 98.11 ± 3.87 –
terolemic rats.
Table 6
Means for insulin level (mU/mL) of rats in different studies.
Studies Diet Study intervals (days) Means
0 28 56
Study I Control 9.11 ± 0.47 9.07 ± 0.67 9.05 ± 0.90 9.07 ± 0.76
Functional 9.07 ± 0.47 9.18 ± 0.45 9.25 ± 0.67 9.16 ± 0.78
Nutraceutical 9.26 ± 0.31 9.47 ± 0.55 9.55 ± 0.78 9.42 ± 0.47
Means 9.14 ± 0.32 9.24 ± 0.65 9.28 ± 0.98 –
Study II Control 10.23 ± 0.51 10.19 ± 0.45 10.18 ± 0.76 10.20 ± 0.87
Functional 10.45 ± 0.65 10.78 ± 0.55 10.89 ± 0.67 10.70 ± 0.65
Nutraceutical 10.78 ± 0.98 11.53 ± 0.65 11.36 ± 0.61 11.22 ± 0.32
Means 10.48 ± 0.87 10.83 ± 0.34 10.82 ± 0.76 –
Study III Control 9.47 ± 0.49 9.45 ± 0.50 9.42 ± 0.32 9.44 ± 0.76
Functional 9.42 ± 0.26 9.51 ± 0.64 9.54 ± 0.98 9.49 ± 0.87
Nutraceutical 9.59 ± 0.35 9.76 ± 0.40 9.89 ± 0.67 10.08 ± 0.39
Means 9.49 ± 0.51 9.57 ± 0.45 9.61 ± 0.62 –
Study I: Normal rats; Study II: Hyperglycemic rats; Study III: Hypercholesterolemic rats.
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level increased as function of time, ranging from (10.45 ± 0.65)
to (10.89 ± 0.67) mU/mL in functional and (10.78 ± 0.98) to
(11.36 ± 0.61) mU/mL in nutraceutical groups, but decreased in
control group from (10.23 ± 0.51) to (10.18 ± 0.76) mU/mL.
However, nutraceutical diet was more effective to enhance in-
sulin secretion (5.41%) trailed by functional diet (4.23%).
Nonetheless, non-signiﬁcant differences due to treatments
were observed in study III comprising high cholesterol diet;
nutraceutical group showed highest insulin level [(10.08 ± 0.39)
mU/mL] but low in functional [(9.49 ± 0.87) mU/mL] and control
groups [(9.44 ± 0.76) mU/mL], respectively. However, insulin
level in functional and nutraceutical increased progressively
from (9.42 ± 0.26) to (9.54 ± 0.98) and from (9.59 ± 0.35) to
(9.89 ± 0.67) mU/mL, respectively. Decisively, functional and
nutraceutical diet holds insulinotropic properties that improved
insulin secretion by 2.07% and 3.21%, correspondingly.
3.5. Hematological study
3.5.1. Red blood cell
Statistical inferences corresponding to red blood indices have
expounded non-signiﬁcant effect of treatments on red blood
cells in different studies while intervals led to momentous var-
iations in study I. Keeping in view, for study I (Table 7), red
blood cells counts were (8.10 ± 0.32), (8.17 ± 0.35) and
(8.39 ± 0.37) × 106/mL in control, functional and nutraceuticalTable 7
Means for red blood cells (106/mL) of rats in different studies.
Studies Diet
0
Study I Control 7.78 ± 0.23
Functional 7.85 ± 0.32
Nutraceutical 7.98 ± 0.28
Means 7.87 ± 0.25
Study II Control 8.93 ± 0.35
Functional 8.88 ± 0.45
Nutraceutical 8.97 ± 0.32
Means 8.92 ± 0.37
Study III Control 9.46 ± 0.47
Functional 9.57 ± 0.54
Nutraceutical 9.63 ± 0.23
Means 9.55 ± 0.48
Study I: Normal rats; Study II: Hyperglycemic rats; Study III: Hypercholesgroups, respectively. However, it increased signiﬁcantly as a
function of intervals that was highest in nutraceutical group from
(7.98 ± 0.28) to (8.45 ± 0.48) × 106/mL. In study II, total red
blood cells were (8.90 ± 0.28) × 106/mL in control, (8.94 ± 0.25)
× 106/mL in functional and (9.05 ± 0.31) × 106/mL in nutra-
ceutical groups. But, it improved from (8.88 ± 0.45) to
(8.99 ± 0.42) × 106/mL and (8.97 ± 0.32) to (9.12 ± 0.44) × 106/
mL for functional and nutraceutical groups, respectively as
compared to control group. In study III, red blood cells for
control, functional and nutraceutical groups were (9.41 ± 0.34),
(9.66 ± 0.38) and (9.75 ± 0.45) × 106/mL that increased with
passage of time in functional and nutraceutical groups.
3.5.2. White blood cell
Mean squares explicated that treatments as well as interaction
have non-momentous changes in white blood cells of rats in
different studies however intervals signiﬁcantly affected white
blood cells in study I and II. Mean values for white blood cells
(Table 8) for control, functional and nutraceutical groups in study I
were (10.17 ± 0.62), (10.18 ± 0.58) and (10.31 ± 0.72) × 103/mL,
respectively. Functional and nutraceutical diets have signiﬁcantly
increased this trait with maximum variations in rat group fed on 5%
citrus peel extract from (10.17 ± 0.57) to (10.40 ± 0.62) × 103/mL. In
study II, total white blood cells were (10.73 ± 0.68) × 103/mL in
control, (10.85 ± 0.72) × 103/mL in functional and (10.86 ± 0.75) ×
103/mL in nutraceutical groups. It was observed that white blood
cells increased signiﬁcantlywithpassageof time thatwere highest inStudy intervals (days) Means
28 56
8.22 ± 0.24 8.32 ± 0.33 8.10 ± 0.32
8.26 ± 0.42 8.40 ± 0.38 8.17 ± 0.35
8.32 ± 0.45 8.45 ± 0.48 8.39 ± 0.37
8.26 ± 0.36 8.39 ± 0.38 –
8.89 ± 0.27 8.88 ± 0.34 8.90 ± 0.28
8.95 ± 0.35 8.99 ± 0.42 8.94 ± 0.25
9.08 ± 0.45 9.12 ± 0.44 9.05 ± 0.31
8.97 ± 0.33 8.99 ± 0.28 –
9.42 ± 0.56 9.37 ± 0.37 9.41 ± 0.34
9.68 ± 0.41 9.74 ± 0.45 9.66 ± 0.38
9.79 ± 0.43 9.84 ± 0.41 9.75 ± 0.45
9.63 ± 0.34 9.65 ± 0.42 –
terolemic rats.
Table 8
Means for white blood cells (103/mL) of rats in different studies.
Studies Diet Study intervals (days) Means
0 28 56
Study I Control 10.13 ± 0.53 10.17 ± 0.69 10.23 ± 0.54 10.17 ± 0.62
Functional 10.08 ± 0.61 10.21 ± 0.59 10.26 ± 0.57 10.18 ± 0.58
Nutraceutical 10.17 ± 0.57 10.36 ± 0.52 10.40 ± 0.62 10.31 ± 0.72
Means 10.12 ± 0.64 10.24 ± 0.59 10.29 ± 0.65 –
Study II Control 10.72 ± 0.87 10.73 ± 0.78 10.75 ± 0.94 10.73 ± 0.68
Functional 10.82 ± 0.54 10.85 ± 0.82 10.90 ± 0.91 10.85 ± 0.72
Nutraceutical 10.79 ± 0.82 10.89 ± 0.75 10.92 ± 0.85 10.86 ± 0.75
Means 10.77 ± 0.67 10.82 ± 0.84 10.86 ± 0.87 –
Study III Control 11.23 ± 0.91 11.26 ± 0.58 11.27 ± 0.72 11.25 ± 0.87
Functional 11.19 ± 0.85 11.33 ± 0.65 11.49 ± 0.64 11.36 ± 0.64
Nutraceutical 11.32 ± 0.80 11.49 ± 0.76 11.54 ± 0.59 11.39 ± 0.58
Means 11.25 ± 0.77 11.30 ± 0.87 11.45 ± 0.97 –
Study I: Normal rats; Study II: Hyperglycemic rats; Study III: Hypercholesterolemic rats.
Table 9
Means for platelets (103/mL) of rats in different studies.
Studies Diet Study intervals (Days) Means
0 28 56
Study I Control 1024.0 ± 30.7 1040.0 ± 31.2 1047.0 ± 52.3 1037.7 ± 31.1
Functional 1031.0 ± 31.2 1044.0 ± 41.1 1051.0 ± 31.5 1042.4 ± 52.0
Nutraceutical 1034.0 ± 41.3 1052.0 ± 52.4 1059.0 ± 31.7 1048.7 ± 55.8
Means 1029.6 ± 31.0 1045.3 ± 41.5 1052.3 ± 42.0 –
Study II Control 1063.0 ± 53.1 1057.0 ± 43.2 1055.0 ± 65.6 1058.3 ± 53.9
Functional 1071.0 ± 32.1 1078.0 ± 33.2 1082.0 ± 48.7 1077.1 ± 57.4
Nutraceutical 1067.0 ± 53.3 1083.0 ± 54.7 1086.0 ± 66.1 1078.7 ± 54.4
Means 1067.0 ± 42.6 1072.7 ± 32.6 1074.3 ± 43.9 –
Study III Control 1049.0 ± 31.4 1043.0 ± 53.3 1041.0 ± 32.1 1044.3 ± 63.7
Functional 1052.0 ± 31.5 1063.0 ± 52.9 1067.0 ± 63.8 1060.9 ± 31.7
Nutraceutical 1061.0 ± 42.4 1079.0 ± 41.9 1084.0 ± 31.8 1074.8 ± 42.2
Means 1054.0 ± 52.7 1061.6 ± 42.3 1064.4 ± 31.9 –
Study I: Normal rats; Study II: Hyperglycemic rats; Study III: Hypercholesterolemic rats.
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In study III, mean values for white blood cells were (11.25 ± 0.87)
(control group), (11.36 ± 0.64) (functional group) and
(11.39 ± 0.58) × 103/mL (nutraceutical group).
3.5.3. Platelet count
It is deduced frommean squares that effect of treatments aswell
as intervals was non-signiﬁcant on platelet count in different
studies. In study I, mean values (Table 9) for control, functional
and nutraceutical groups changed from (1 037.7) ± 31.1),
(1 042.4 ± 52.0) to (1 048.7 ± 55.8) × 103/mL, respectively but
increased non-signiﬁcantly in all groups. However, in study II,
higher platelet counts [(1 077.18±57.40) and (1 078.73±54.40) ×
103/mL] were noted in functional and nutraceutical groups,
correspondingly as compared to (1 058.33 ± 53.90) × 103/mL in
control group. Likewise, in study III, platelet count in control
group was (1 044.33 ± 63.70) × 103/mL, but improved to
(1 060.96 ±31.70) × 103/mL in functional and (1 074.81±42.20) ×
103/mL in nutraceutical groups.
4. Discussion
The concept of health and nutrition paradigm has signiﬁ-
cantly modiﬁed consumer preferences in the selection of food
for the last few decades. Nowadays, phytochemical rich food isconsidered as a vehicle to maintain good health besides sup-
plying nutrients for proper body functioning. Therefore, core
attention was paid to illuminate the health promoting role of
citrus peel; an industrial by-product of fruit processing unit.
Considering the fact, present project was designed to investigate
the prophylactic worth of citrus peel against various life style
related disorders like hyperglycemia and hypercholesterolemia.
In this context, efﬁcacy trial was conducted by designing three
different studies named as study I, II & III. The study I consisted
of normal rats; rats in study II were fed on high sucrose diet to
induce hyperglycemia and rats in study III were provided with
high cholesterol diet to induce hypercholesterolemic conditions.
Previously, the research investigation of Menichini et al. [30],
has already conﬁrmed that citrus peel can be effectively
employed to alleviate metabolic syndrome like coronary heart
diseases by decreasing free fatty acids, hepatic and plasma
triglycerides and increasing fecal excretion of triglycerides.
Oral administration of citrus peel extract (600 mg/kg) can
reduce the plasma triglycerides in hypercholestrolemic subjects
as compared to control group. It was accredited to the ability
of citrus ﬂavonoids to prevent oleic acid conjugation in
triglycerides thus overall decrease plasma cholesterol level.
Current explorations were in line with the outcomes of
Abdelbaky et al. [31], who analyzed effect of orange, grapefruit
& lemon peel powder and their extracts on biochemical
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signiﬁcant differences in feed intake of rat groups fed sepa-
rately on peel powder of various citrus fruits (orange, grapefruits
and lemon) and their respective extracts. Accordingly, signiﬁ-
cant reduction was noticed in body weight gain ratio of rats fed
on citrus peel supplemented diet as compared to control group.
The reason behind weight reduction of treated rats is the gain in
liver weight of control hyperlipidemic group while the weight of
heart, kidney, lungs and spleen did not change considerably in
all groups. This may be attributed to liver high cholesterol
synthesis rate in control group.
Moreover, Park et al. [32], explored citrus peel as regulator of
lipoprotein metabolism in rats against diet induced fatty liver.
They provided experimental animal with escalating doses of
citrus peel extracts; 278, 2.87 and 576 mL/rat/day for 6 weeks.
Results depicted signiﬁcant alleviation in total cholesterol of rats
fed on high doses of peel extract as compared to group relying
on low doses. Further, Mollace et al. [33] also recorded signiﬁcant
improvement in HDL while total cholesterol, LDL and plasma
triglycerides decreased in hypercholesterolemic rats fed on citrus
ﬂavonoid rich extract (10 mg/kg and 20 mg/kg) for the course of
one month. Citrus peel bioactive moieties trigger the activation of
receptor cells that incorporate excess LDL and triglycerides into
liver and adipose tissue rather than circulating in vascular system
to develop hard plaque. Previously, Abdelbaky et al. [31],
concluded that orange peel extract was most potent in reducing
plasma LDL (12.47 mg/dL) while grapefruit peel powder was
least efﬁcient (49.65 mg/dL). It may be attributed to hesperidin
contents of orange peel that are more as compared to other citrus
varieties. This hypothesis was afﬁrmed by Wang et al. [15], who
summarized that hesperidin has potential to prevent fatty
degeneration of liver thus control hepatic lipid metabolism.
Regarding the hyperglycemic perspectives of citrus peel,
Fernandes et al. [34] observed the effect of citrus peel ﬂavonoids
to minimize adverse changes in streptozotocin induced diabetic
rat. Daily intake of peel ﬂavonoids tends to stimulate the action
of pancreatic beta cells to normalize insulin level. In another
experiment, Kabra et al. [35] studied effect of citrus ﬂavonoid
(200 mg/kg and 400 mg/kg body weight) on diabetic induced
complications in rats. They assessed that oral administration of
peel extract signiﬁcantly decline (P < 0.01) blood glucose level
in diabetic rat after 28 and 56 d (297 mg/dL and 133.4 mg/dL,
respectively) in contrast to diabetic control (429.2 mg/dL and
485 mg/dL, correspondingly). Oral administration of citrus
bioﬂavonoids reactivates insulin secreting cells and regularizes
the disparities due to glycated Hb. Furthermore, Menichini
et al. [30], evaluated nutraceutical effect of citrus peel extract
(300 mg/kg and 600 mg/kg body weight of rat) on glucose
homeostasis as well as hematological parameters. They
concluded that peel extract was more effective to normalize
glucose and serum lipid proﬁle while non-signiﬁcant effect was
observed for all hematological attributes.
Conclusively, citrus peel extract and powder exhibited a
decline in total cholesterol, triglycerides, LDL and glucose
levels by the virtue of nutraceutical and functional diets.
Regarding the levels of insulin and HDL, it improved by dietary
inclusions. Nevertheless, citrus peel nutraceutical enriched diet
regularizes glycemic and lipidemic parameters more effectively
as compared to citrus peel powder. In a nutshell, proper utili-
zation of agro-waste material like citrus peel in diet based
therapies is a economical, accessible and cheap source to address
life style associated diseases.Conﬂict of interest statement
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